Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AMDI has developed a rapid (<10 min) multiplex RT-PCR point-of-care diagnostic system for urgent care, primary care, retail clinics, and office labs. The company also offers a serum-based Q-NAb test that correlates with BSL‑3 laboratory neutralization assays. Their technology leverages microfluidics, protein engineering, and cloud connectivity to deliver fast actionable results at the point of care. Clinical validation data has not been detailed in public sources but the company claims high accuracy rates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Autonomous Medical Devices.